Knee Osteoarthritis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: unilateral HTO ASA-PS 1 or 2
Exclusion criteria
Exclusion criteria: DM patient with neuropathy neuromuscular disease vascular insufficiency of the lower limb cognitive dysfunction BMI over 35 renal impairment(eGFR under 60) liver dysfunction allergy to the drug used stomach ulcer pregnancy or lactation QTc over 0.44 enable to take the block position not appropriate for the study, dicision made by the doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of IV PCA boluses | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of patients accomplished the trial, postoperative visual analog scale score (VAS score) at rest and at motion, the distribution of pain, the time of initial IV PCA bolus, postoperative nausea and vomiting (PONV), postoperative motor and neurological impairment and total amount of opioid used intraoperatively. | — |
Countries
Japan
Contacts
Yokohama City University Hospital Anesthesiology